OCRL and oculocerebrorenal syndrome: Recently, Rendu et al. designed a successful exon-skipping strategy able to restore significant levels of OCRL mRNA and protein in a Lowe syndrome patient with an intronic mutation that induces incorporation of intronic sequences in the mRNA and leads to loss of OCRL1 protein [67].